LQDA
Price
$26.94
Change
-$1.37 (-4.84%)
Updated
Nov 13 closing price
Capitalization
2.34B
118 days until earnings call
Intraday BUY SELL Signals
UNCY
Price
$5.33
Change
+$0.19 (+3.70%)
Updated
Nov 13 closing price
Capitalization
94.14M
Intraday BUY SELL Signals
Interact to see
Advertisement

LQDA vs UNCY

Header iconLQDA vs UNCY Comparison
Open Charts LQDA vs UNCYBanner chart's image
Liquidia
Price$26.94
Change-$1.37 (-4.84%)
Volume$2.04M
Capitalization2.34B
Unicycive Therapeutics
Price$5.33
Change+$0.19 (+3.70%)
Volume$515.31K
Capitalization94.14M
LQDA vs UNCY Comparison Chart in %
LQDA
Daily Signal:
Gain/Loss:
UNCY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LQDA vs. UNCY commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LQDA is a Buy and UNCY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (LQDA: $26.94 vs. UNCY: $5.33)
Brand notoriety: LQDA and UNCY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LQDA: 78% vs. UNCY: 107%
Market capitalization -- LQDA: $2.34B vs. UNCY: $94.14M
LQDA [@Biotechnology] is valued at $2.34B. UNCY’s [@Biotechnology] market capitalization is $94.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LQDA’s FA Score shows that 1 FA rating(s) are green whileUNCY’s FA Score has 0 green FA rating(s).

  • LQDA’s FA Score: 1 green, 4 red.
  • UNCY’s FA Score: 0 green, 5 red.
According to our system of comparison, both LQDA and UNCY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LQDA’s TA Score shows that 6 TA indicator(s) are bullish while UNCY’s TA Score has 4 bullish TA indicator(s).

  • LQDA’s TA Score: 6 bullish, 4 bearish.
  • UNCY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, LQDA is a better buy in the short-term than UNCY.

Price Growth

LQDA (@Biotechnology) experienced а +5.23% price change this week, while UNCY (@Biotechnology) price change was +18.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

LQDA is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LQDA($2.34B) has a higher market cap than UNCY($94.1M). LQDA YTD gains are higher at: 140.731 vs. UNCY (-35.281). UNCY has higher annual earnings (EBITDA): -30.92M vs. LQDA (-133.4M). LQDA has more cash in the bank: 173M vs. UNCY (22.3M). UNCY has less debt than LQDA: UNCY (476K) vs LQDA (200M). LQDA has higher revenues than UNCY: LQDA (19.3M) vs UNCY (0).
LQDAUNCYLQDA / UNCY
Capitalization2.34B94.1M2,490%
EBITDA-133.4M-30.92M431%
Gain YTD140.731-35.281-399%
P/E RatioN/AN/A-
Revenue19.3M0-
Total Cash173M22.3M776%
Total Debt200M476K42,017%
FUNDAMENTALS RATINGS
LQDA: Fundamental Ratings
LQDA
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
9
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LQDAUNCY
RSI
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LQDA
Daily Signal:
Gain/Loss:
UNCY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OCGPF2.57N/A
N/A
Oceana Group Ltd.
BACRP218.25N/A
N/A
Bank of America Corp.
GPFOF2.43N/A
N/A
Grupo Financiero Inbursa, S.A. de C.V.
SEBYY5.47N/A
N/A
SEB S.A.
ZHYBF2.02N/A
N/A
Zhong Yuan Bio-Technology Holdings Ltd

LQDA and

Correlation & Price change

A.I.dvisor tells us that LQDA and ATOS have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LQDA and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LQDA
1D Price
Change %
LQDA100%
+1.91%
ATOS - LQDA
33%
Poorly correlated
-1.74%
UNCY - LQDA
32%
Poorly correlated
+7.31%
KYMR - LQDA
32%
Poorly correlated
+0.25%
AXON - LQDA
32%
Poorly correlated
-0.47%
TPST - LQDA
31%
Poorly correlated
-9.56%
More

UNCY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UNCY has been loosely correlated with INDP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if UNCY jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UNCY
1D Price
Change %
UNCY100%
+7.31%
INDP - UNCY
51%
Loosely correlated
+6.25%
CDTX - UNCY
50%
Loosely correlated
-0.99%
ICU - UNCY
43%
Loosely correlated
+1.90%
IBO - UNCY
37%
Loosely correlated
-5.99%
UTHR - UNCY
32%
Poorly correlated
+0.51%
More